Complejo Hospitalario de Toledo -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2021

  1. Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

    OncoImmunology, Vol. 10, Núm. 1

2018

  1. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

    European Respiratory Journal

1999

  1. Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin

    Cancer, Vol. 86, Núm. 8, pp. 1463-1469

1996

  1. Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen

    Cancer Chemotherapy and Pharmacology, Vol. 38, Núm. 2, pp. 191-194